Showing results (31-40 of 363) with videos related to
Sort By:
Pageof 37
European Journal of Clinical Pharmacology|September 12, 2006
The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effectsH Knauf, M A Bailey, G Hasenfuss, et al.British Journal of Pharmacology|May 1, 1992
Effects of a new pteridine derivative on urinary sodium, potassium and magnesium excretion in conscious saline-loaded ratsT Netzer, F Ullrich, H Priewer, et al.Archiv Der Pharmazie|August 1, 1992
Bioavailability study of two different verapamil formulationsC Horne, G Stenzhorn, H Blume, et al.Arzneimittel-Forschung|January 1, 1980
Independent of etozolin elimination of kidney function. Single dose experiments in patients with renal insufficiencyH Knauf, G Hasenfuss, U Wais, et al.Arzneimittel-Forschung|December 1, 1987
Altered kinetics of etozolin and its active metabolite ozolinone in hepatitis and hepatic cirrhosis with ascitesH Knauf, M Missmahl, J Schölmerich, et al.Pharmaceutical Research|February 1, 1987
Dissociation of the natriuretic and antikaliuretic properties of triamterene derivatives by dose-response experimentsH Priewer, E Wolf, H Kraft, et al.European Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics of amiloride in renal and hepatic diseaseH Spahn, K Reuter, E Mutschler, et al.European Journal of Clinical Pharmacology|January 1, 1985
Pharmacokinetics of carteolol in relation to renal functionG Hasenfuss, M Schäfer-Korting, H Knauf, et al.Die Pharmazie|June 1, 1995
Investigations on the acute toxicity of acidic and basic triamterene derivativesH Priewer, E Wolf, F Ullrich, et al.Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Pharmacokinetics of triamtereneE Mutschler, H J Gilfrich, H Knauf, et al.Pageof 37